| BID | 0.7021 | ASK | 0.7400 | ||
| Open | 0.7070 | Previous Close | 0.7190 | ||
| Pre-Market | - | After-Market | 0.72 | ||
| - - | 0.00 -0.10% |
| Target Price | 15.00 | Analyst Rating | Strong Buy 1.00 | |
| Potential % | 1.98K | Finscreener Ranking | — - | |
| Insiders Trans % 3/6/12 mo. | -/-/- | Value Ranking | — - | |
| Insiders Value % 3/6/12 mo. | -/-/- | Growth Ranking | — - | |
| Insiders Shares Cnt. % 3/6/12 mo. | -/-/- | Income Ranking | — - | |
| Price Range Ratio 52W % | 0.83 | Earnings Rating | — | |
| Market Cap | 3.87M | Earnings Date | 20th Apr 2023 | |
| Alpha | -0.14 | Standard Deviation | 0.16 | |
| Beta | 1.05 |
Today's Price Range 0.70010.7200 | 52W Range 0.65019.02 |
Summary:
Sell
| Technical Indicators: | Neutral |
| Moving Averages: | Strong Sell |
| Performance | |||
|---|---|---|---|
| 1 Week | -3.81% | ||
| 1 Month | -2.70% | ||
| 3 Months | -49.30% | ||
| 6 Months | -69.75% | ||
| 1 Year | 6.95% | ||
| 3 Years | - | ||
| 5 Years | - | ||
| 10 Years | - |
| Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
ROE (5Y Avg) | -275.86 | |||
ROE last 12 Months | -777.65 | |||
ROA (5Y Avg) | -47.71 | |||
ROA last 12 Months | -98.46 | |||
ROC (5Y Avg) | - | |||
ROC last 12 Months | -153.04 | |||
Return on invested Capital Q | - | |||
Return on invested Capital Y | -168.66 | |||
Assets Turnover | 0.00 | |||
Receivables Turnover | 0.00 |
| Valuation | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| -0.10 | ||||
| 1.37 | ||||
| - | ||||
| - | ||||
| -0.70 | ||||
| -2.01 | ||||
| 2.64 | ||||
| 0.30 | ||||
| -1 297 140.00 | ||||
| Forward PE | - | |||
| PEG | - |
| Financial Strength | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 1.30 | ||||
| 1.40 | ||||
| 0.52 | ||||
| 2.68 | ||||
| -50.30 | ||||
| Leverage Ratio | -2.00 |
| Profitability | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| - | ||||
| - | ||||
| - | ||||
| - | ||||
| - |
| Revenue | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 0.00 | ||||
| 0.00 | ||||
| - | ||||
| - |
| Dividends | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| - | ||||
| - | ||||
| - | ||||
| - | ||||
| Payout ratio | - |
| Earnings History | Estimate | Reported | Surprise % |
|---|---|---|---|
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| Earnings Per End | Estimate | Revision % | Trend |
|---|---|---|---|
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| Next Report Date | - |
| Estimated EPS Next Report | - |
| Estimates Count | - |
| EPS Growth Next 5 Years % | - |
| Volume Overview | |
|---|---|
| Volume | 5.76K |
| Shares Outstanding | 5.37K |
| Shares Float | 5.13M |
| Trades Count | 20 |
| Dollar Volume | 4.04K |
| Avg. Volume | 387.03K |
| Avg. Weekly Volume | 8.01K |
| Avg. Monthly Volume | 26.64K |
| Avg. Quarterly Volume | 1.13M |
Biophytis SA (NASDAQ: BPTS) stock closed at 0.72 per share at the end of the most recent trading day (a 0.14% change compared to the prior day closing price) with a volume of 5.76K shares and market capitalization of 3.87M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the industry, sector and employs 31 people. Biophytis SA CEO is .
The one-year performance of Biophytis SA stock is 6.95%, while year-to-date (YTD) performance is 82.23%. BPTS stock has a five-year performance of %. Its 52-week range is between 0.6501 and 9.024, which gives BPTS stock a 52-week price range ratio of 0.83%
Biophytis SA currently has a PE ratio of -0.10, a price-to-book (PB) ratio of 1.37, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -98.46%, a ROC of -153.04% and a ROE of -777.65%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.
Of the last four earnings reports from Biophytis SA, there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Biophytis SA’s next earnings report date is -.
The consensus rating of Wall Street analysts for Biophytis SA is Strong Buy (1), with a target price of $15, which is +1 983.33% compared to the current price. The earnings rating for Biophytis SA stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Biophytis SA has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Biophytis SA has a Sell technical analysis rating based on Technical Indicators (ADX : 36.39, ATR14 : 0.08, CCI20 : -85.53, Chaikin Money Flow : 0.37, MACD : -0.05, Money Flow Index : 62.00, ROC : -1.57, RSI : 41.79, STOCH (14,3) : 43.09, STOCH RSI : 0.45, UO : 68.61, Williams %R : -56.91), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Biophytis SA in the last 12-months were:
Biophytis SA
Biophytis SA is a France-based biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases.
CEO:
Telephone: +33 144272300
Address: 4 place Jussieu, Paris 75252, , FR
Number of employees: 31
TipRanks News for BPTS
Thu, 28 Sep 2023 13:21 GMT Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (OtherSNYNF), Biophytis (BPTS) and Curaleaf Holdings (OtherCURLF)
- TipRanks. All rights reserved.
